TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34884387

Group type: EXPERIMENTAL
Intervention: Transbronchial lung cryobiopsy (TBLC)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Transbronchial forceps biopsy (TBLF)
Number of subjects: 359
Study: 32979512

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg on day 1) and nab-paclitaxel (125 mg/m2 on day 1 and day 8, every 3 weeks)
Number of subjects: 70
Study: 35525251

Group type: EXPERIMENTAL
Intervention: tenecteplase (0·25 mg/kg, maximum 25 mg, intravenous bolus over 10 s)
Number of subjects: 104

Group type: COMPARATOR
Intervention: alteplase (0·9 mg/kg, maximum 90 mg, 10% as bolus over 1 min and 90% as infusion over 1 h)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: tenecteplase
Number of subjects: 104

Group type: COMPARATOR
Intervention: alteplase
Number of subjects: 104
Study: 32416333

Group type: EXPERIMENTAL
Intervention: Convergent hybrid procedure
Number of subjects: 153

Group type: COMPARATOR
Intervention: Endocardial catheter ablation
Number of subjects: 153
Study: 35231024

Group type: EXPERIMENTAL
Intervention: Monthly follow-up (n=1,976)
Number of subjects: 3945

Group type: COMPARATOR
Intervention: Weekly follow-up (n=1,802)
Number of subjects: 3945

Group type: EXPERIMENTAL
Intervention: Monthly follow-up (n=976)
Number of subjects: 3945

Group type: COMPARATOR
Intervention: Weekly follow-up (n=1,005)
Number of subjects: 3945

Group type: EXPERIMENTAL
Intervention: Monthly follow-up (n=1,873)
Number of subjects: 3945

Group type: COMPARATOR
Intervention: Weekly follow-up (n=1,721)
Number of subjects: 3945
Study: 32472590

Group type: EXPERIMENTAL
Intervention: Combined TACE and sorafenib
Number of subjects: 64

Group type: COMPARATOR
Intervention: TACE alone (monotherapy group)
Number of subjects: 64
Study: 33178135

Group type: EXPERIMENTAL
Intervention: NG-Ex (45 min of cycling exercise after 3.5 h of normoglycemia)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HG-Ex (45 min of cycling exercise after 3.5 h of steady-state hyperglycemia)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FG-Ex (45 min of cycling exercise after 3.5 h of fluctuating hyperglycemia)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON (no exercise)
Number of subjects: 12
Study: 34560112

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg each, 2 tablets, total 6 mg)
Number of subjects: 64
Study: 33476237

Group type: EXPERIMENTAL
Intervention: Bridges (1:1 savings match rate)
Number of subjects: 1383

Group type: EXPERIMENTAL
Intervention: Bridges PLUS (2:1 savings match rate)
Number of subjects: 1383

Group type: EXPERIMENTAL
Intervention: Bridges
Number of subjects: 1383

Group type: EXPERIMENTAL
Intervention: Bridges PLUS
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1383
Study: 32203751

Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 157

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 157
Study: 35991150

Group type: EXPERIMENTAL
Intervention: PBL combined with situational simulation teaching method
Number of subjects: 120
Study: 34162631

Group type: EXPERIMENTAL
Intervention: HamRaah (mHealth intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 0
Study: 32532564

Group type: EXPERIMENTAL
Intervention: Ultrasound guided ankle block
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blind local infiltration
Number of subjects: 0
Study: 35389364

Group type: EXPERIMENTAL
Intervention: Social norming messages
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Fear appeal messages
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control group messages
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Fear appeal messages (subgroup analysis)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Social norming messages (subgroup analysis)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Social norming messages (among consistent wearers at baseline)
Number of subjects: 391
Study: 34684528

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 491

Group type: COMPARATOR
Intervention: Non-PCOS group
Number of subjects: 491
Study: 33362194

Group type: EXPERIMENTAL
Intervention: Waist circumference cutoff of 90 cm in men
Number of subjects: 3387

Group type: EXPERIMENTAL
Intervention: Waist circumference cutoff of 86 cm in women
Number of subjects: 3387

Group type: EXPERIMENTAL
Intervention: Prevalence of abdominal obesity
Number of subjects: 3387
Study: 35149320

Group type: EXPERIMENTAL
Intervention: Dietary intake of fiber
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Dietary intake of magnesium
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Dietary intake of niacin
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Dietary intake of thiamine
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Dietary intake of folate
Number of subjects: 1521
Study: 33961650

Group type: EXPERIMENTAL
Intervention: Tuberculosis (TB) cohort
Number of subjects: 6934

Group type: COMPARATOR
Intervention: No Tuberculosis (TB) exposure (control cohort)
Number of subjects: 6934

Group type: EXPERIMENTAL
Intervention: TB cohort
Number of subjects: 6934

Group type: EXPERIMENTAL
Intervention: TB cohort with comorbidities
Number of subjects: 6934

Group type: EXPERIMENTAL
Intervention: Primary cancer types in TB cohort
Number of subjects: 6934
Study: 33225804

Group type: EXPERIMENTAL
Intervention: Online psychoeducation curriculum delivered via 5 to 10-minute videos over 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 29
Study: 35723939

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (24-unit dose individualized according to crow's feet line distribution)
Number of subjects: 323
Study: 33479442

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) with low-pressure pneumoperitoneum (PP) at 8 mmHg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB) with high-pressure pneumoperitoneum (PP) at 12 mmHg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Moderate NMB group
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Deep NMB group
Number of subjects: 74
Study: 34412104

Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg nasal spray plus standard of care
Number of subjects: 456

Group type: COMPARATOR
Intervention: Placebo nasal spray plus standard of care
Number of subjects: 456
Study: 33058957

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate (LC) diet: 14% energy carbohydrate, 28% protein, 58% fat (<10% saturated fat)
Number of subjects: 115

Group type: COMPARATOR
Intervention: High-carbohydrate (HC) diet: 53% carbohydrate, 17% protein, 30% fat (<10% saturated fat)
Number of subjects: 115
Study: 33168360

Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy with disposable intraoral dental camera protection cap
Number of subjects: 12

Group type: COMPARATOR
Intervention: Videolaryngoscopy without disposable intraoral dental camera protection cap
Number of subjects: 12
Study: 33474952

Group type: EXPERIMENTAL
Intervention: New silicone drainage plug (model group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional plug (control group)
Number of subjects: 74
Study: 33212907

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus HN001 probiotic
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 35123210

Group type: EXPERIMENTAL
Intervention: Estradiol treatment
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 126
Study: 33094465

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined training (Pilates + Aerobic exercises)
Number of subjects: 30
Study: 34939776

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32072695

Group type: EXPERIMENTAL
Intervention: Nutrilite™ Multi Carotene supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35445358

Group type: EXPERIMENTAL
Intervention: Plasma amyloid-beta (Aβ) alone
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Plasma amyloid-beta (Aβ) plus multiple plasma biomarkers
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Combined assessment of Aβ, GDF15, and MCP1
Number of subjects: 401
Study: 35685555

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study: 34096993

Group type: EXPERIMENTAL
Intervention: Genetic liability to ADHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic liability to ASD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher educational attainment (EA)
Number of subjects: 0
Study: 36441522

Group type: EXPERIMENTAL
Intervention: Weekly oral doses of vitamin D3, 14,000 IU for 3 years
Number of subjects: 8851

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8851

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 8851
Study: 33998163

Group type: EXPERIMENTAL
Intervention: Candesartan 4 mg q.d.
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (patients unwilling to take medication)
Number of subjects: 195
Study: 32439926

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 100
Study: 34756607

Group type: EXPERIMENTAL
Intervention: Simplified technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 60
Study: 33881700

Group type: EXPERIMENTAL
Intervention: Moringa Oleifera leaves supplementation (MOG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (COG)
Number of subjects: 200
Study: 35457686

Group type: EXPERIMENTAL
Intervention: Patient empowerment (measured by DES-SF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33491321

Group type: EXPERIMENTAL
Intervention: Parent-Based Treatment (PBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Family-Based Treatment (FBT)
Number of subjects: 150
Study: 33174856

Group type: EXPERIMENTAL
Intervention: Modified problem-solving intervention delivered via telephone and 8 asynchronous online sessions.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care group with no changes in information or discharge planning, access to existing VA resources.
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Modified problem-solving intervention
Number of subjects: 240
Study: 34536915

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg rocuronium
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline (no neuromuscular block)
Number of subjects: 66
Study: 33602439

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy after 3-month dual-antiplatelet therapy (DAPT)
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy after 3-month DAPT
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Ticagrelor-based 12-month DAPT
Number of subjects: 1103
Study: 35325055

Group type: EXPERIMENTAL
Intervention: 5-day course of antibiotics
Number of subjects: 152

Group type: COMPARATOR
Intervention: 24-h course of antibiotics
Number of subjects: 152
Study: 34791911

Group type: EXPERIMENTAL
Intervention: Neck strengthening exerciser device (Group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Regular neck exercise (Group B)
Number of subjects: 58
Study: 34342015

Group type: EXPERIMENTAL
Intervention: BMI + SFAS
Number of subjects: 393

Group type: COMPARATOR
Intervention: BMI + RT
Number of subjects: 393

Group type: COMPARATOR
Intervention: AO
Number of subjects: 393
Study: 36183567

Group type: EXPERIMENTAL
Intervention: Parent-administered intervention in NICU
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study: 33036254

Group type: EXPERIMENTAL
Intervention: Combined treatment with poziotinib and manidipine
Number of subjects: 0
Study: 35259151

Group type: EXPERIMENTAL
Intervention: Asibonisane Community Responses Program (Stepping Stones)
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: Baseline treatment levels for those living with HIV
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: HIV testing in the last six months
Number of subjects: 1528
Study: 34339623

Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab (840 mg loading dose, then 420 mg every 3 weeks for pertuzumab; 8 mg/kg loading dose, then 6 mg/kg every 3 weeks for trastuzumab)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab
Number of subjects: 39
Study: 34560813

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 149

Group type: COMPARATOR
Intervention: Nondirective intervention
Number of subjects: 149
Study: 32162420

Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (4:1 ratio: buprenorphine 2 mg + naloxone 0.5 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (2:1 ratio: buprenorphine 2 mg + naloxone 1 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (1:1 ratio: buprenorphine 2 mg + naloxone 2 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Buprenorphine alone (2 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pheniramine maleate (45.5 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study: 35839637

Group type: EXPERIMENTAL
Intervention: Active rTMS treatment (n = 29)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham treatment (n = 27)
Number of subjects: 56
Study: 34126984

Group type: EXPERIMENTAL
Intervention: Fluoride interventions (specific types and dosages not mentioned)
Number of subjects: 0
Study: 34792177

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Zolpidem (Zol)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 211
Study: 32924312

Group type: EXPERIMENTAL
Intervention: Dentin surface cleaning
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dentin surface roughening with round bur plus flowable composite
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dentin surface roughening/cervical groove preparation with round bur
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dentin surface roughening/cervical groove preparation with round bur plus flowable composite
Number of subjects: 85

Group type: COMPARATOR
Intervention: No preparation (cavity cleaning only)
Number of subjects: 85
Study: 35822275

Group type: EXPERIMENTAL
Intervention: Digital health technologies (three types)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 33059755

Group type: EXPERIMENTAL
Intervention: Tailored psychological intervention plus usual care including referral to pulmonary rehabilitation (PR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care including referral to pulmonary rehabilitation (PR)
Number of subjects: 0
Study: 33577167

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Fractionation
Number of subjects: 0
Study: 32142970

Group type: EXPERIMENTAL
Intervention: Watermelon puree (100% daily for 6 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 36356913

Group type: COMPARATOR
Intervention: Covert ordering intervention (products ordered by carbon footprint without explicit information)
Number of subjects: 1842

Group type: COMPARATOR
Intervention: Overt ordering intervention (products ordered by carbon footprint with explicit information)
Number of subjects: 1842

Group type: COMPARATOR
Intervention: Control arm (products randomly ordered)
Number of subjects: 1842
Study: 34264943

Group type: EXPERIMENTAL
Intervention: Intervention stores (moved 26 meat-free products into the meat aisle)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control stores (no change in product placement)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Intervention stores
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control stores
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Intervention stores (Phase II with enhanced intervention)
Number of subjects: 108
Study: 34321303

Group type: EXPERIMENTAL
Intervention: Strategy-based intervention (14 face-to-face sessions, 60 minutes each) focusing on text-level reading comprehension.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waiting period (control group).
Number of subjects: 24
Study: 36267853

Group type: EXPERIMENTAL
Intervention: Jiuwei Zhenxin granules (single drug group)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Jiuwei Zhenxin granules and alprazolam (combination group)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the combination treatment)
Number of subjects: 710
Study: 35865520

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo vaccination
Number of subjects: 301
Study: 34553670

Group type: EXPERIMENTAL
Intervention: Intra-operative mapping of lymphatic leakage with peri-incisional methylene blue injection and clipping of lymphatics
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study: 35745249

Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with plant proteins (PB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional wheat biscuits (CB)
Number of subjects: 70
Study: 33630712

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Aerobic + Resistance Training (A+RT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 61
Study: 32826390

Group type: EXPERIMENTAL
Intervention: Uncovered stent
Number of subjects: 60

Group type: COMPARATOR
Intervention: Covered stent
Number of subjects: 60
Study: 35221689

Group type: EXPERIMENTAL
Intervention: Laparoscopic aortobifemoral bypass (LABFB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Open aortobifemoral bypass (OABFB)
Number of subjects: 71
Study: 33016169

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment and Hall Technique (ART‐HT)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Usual care options (control)
Number of subjects: 338
Study: 33136625

Group type: EXPERIMENTAL
Intervention: O‐WARRM (100 words)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: E‐WARRM (20 words, 5 runs)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Run 1 of the E‐WARRM
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: All five runs from the three E‐WARRM randomizations
Number of subjects: 72
Study: 34979361

Group type: EXPERIMENTAL
Intervention: Community‐based Bilingual Doulas (CBDs)
Number of subjects: 35
Study: 34049574

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 151
Study: 35652236

Group type: EXPERIMENTAL
Intervention: Healing by secondary intention without planned postoperative compression
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Wound infections
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Hospital admissions
Number of subjects: 58
Study: 33089408

Group type: EXPERIMENTAL
Intervention: 20-mg temozolomide capsules (TOZ309)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 100-mg temozolomide capsules (TOZ309)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Temodal® capsules
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both TOZ309 and Temodal®
Number of subjects: 29
Study: 36415779

Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Decoupling (DC)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Decoupling in sensu (DC-is)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Concurrent application of multiple techniques
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Standard DC and HRT
Number of subjects: 334

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 334
Study: 33058277

Group type: EXPERIMENTAL
Intervention: ESS-P
Number of subjects: 57

Group type: COMPARATOR
Intervention: Minimally enhanced treatment as usual (Control)
Number of subjects: 57
Study: 32781263

Group type: EXPERIMENTAL
Intervention: Sintilimab 200 mg plus pemetrexed and platinum
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo plus pemetrexed and platinum
Number of subjects: 397
Study: 33934719

Group type: EXPERIMENTAL
Intervention: Universal, standardized, high-fidelity toddler screening
Number of subjects: 3450

Group type: COMPARATOR
Intervention: Usual care ASD detection strategies
Number of subjects: 3450

Group type: EXPERIMENTAL
Intervention: Early Start Denver Model intervention
Number of subjects: 3450

Group type: EXPERIMENTAL
Intervention: ASD symptom severity measured by Brief Observation of Social Communication Change (BOSCC)
Number of subjects: 3450

Group type: EXPERIMENTAL
Intervention: Cognitive functioning measured by Mullen Scales of Early Learning (MSEL) and Differential Abilities Scale‐II (DAS‐II)
Number of subjects: 3450

Group type: EXPERIMENTAL
Intervention: Adaptive functioning, ASD symptoms, and kindergarten readiness
Number of subjects: 3450

Group type: EXPERIMENTAL
Intervention: Parent stress and empowerment
Number of subjects: 3450
Study: 33797479

Group type: EXPERIMENTAL
Intervention: Generation 7 Combat Application Tourniquet (CAT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tactical Mechanical Tourniquet (TMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SOF Tactical Tourniquet-Wide (SOFTT-W)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All tourniquets after subject maneuvers
Number of subjects: 0
Study: 34613358

Group type: EXPERIMENTAL
Intervention: Vasopressin and steroids
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32204155

Group type: EXPERIMENTAL
Intervention: Listening to the recitation of Qur'an (Ar-Rahman surah)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 32569130

Group type: EXPERIMENTAL
Intervention: Traditional (TR) set configuration
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cluster (CL) set configuration
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Rest Redistribution (RR) set configuration
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 31